Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolates

被引:15
作者
Charretier, Yannick [1 ]
Koehler, Thilo [2 ]
Cecchini, Tiphaine [3 ,4 ]
Bardet, Chloe [5 ,6 ]
Cherkaoui, Abdessalam [7 ]
Llanes, Catherine [8 ]
Bogaerts, Pierre [9 ]
Chatellier, Sonia [10 ]
Charrier, Jean-Philippe [4 ]
Schrenzel, Jacques [1 ,7 ]
机构
[1] Univ Hosp Geneva, Genom Res Lab, Infect Dis Serv, CH-1211 Geneva 14, Switzerland
[2] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland
[3] Univ Lyon 1, CNRS, Inst Analyt Sci, Joint Res Unit 5280, F-69622 Villeurbanne, France
[4] BioMerieux SA, Technol Res Dept, Marcy Letoile, France
[5] Univ Limoges, INSERM, UMR1092, Limoges, France
[6] BioMerieux SA, MD3, Marcy Letoile, France
[7] Univ Hosp Geneva, Dept Genet & Lab Med, Bacteriol Lab, CH-1211 Geneva 14, Switzerland
[8] Univ Franche Comte, Lab Bacteriol, EA4266, F-25030 Besancon, France
[9] CHU Dinant Godinne UCL Namur, Lab Microbiol, Yvoir, Belgium
[10] BioMerieux SA, Microbiol Unit, La Balme Les Grottes, France
关键词
SRM; Pseudomonas aeruginosa; multidrug efflux system; AmpC cephalosporinase; OprD porin; carbapenem resistance; cephalosporin resistance; RT-qPCR; MULTIDRUG EFFLUX SYSTEM; MEXE-MEXF-OPRN; REAL-TIME-PCR; CYSTIC-FIBROSIS; QUANTITATIVE PROTEOMICS; OUTER-MEMBRANE; EXPRESSION; PEPTIDES; AMINOGLYCOSIDES; OVEREXPRESSION;
D O I
10.3389/fmicb.2015.00081
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Both acquired and intrinsic mechanisms play a crucial role in Pseudomonas aeruginosa antibiotic resistance. Many clinically relevant resistance mechanisms result from changes in gene expression, namely multidrug efflux pump overproduction, AmpC beta-lactamase induction or derepression, and inactivation or repression of the carbapenem-specific porin OprD. Changes in gene expression are usually assessed using reverse-transcription quantitative real-time PCR (RT-qPCR) assays. Here, we evaluated label-free Selected Reaction Monitoring (SRM)-based mass spectrometry to directly quantify proteins involved in antibiotic resistance. We evaluated the label-free SRM using a defined set of P. aeruginosa isolates with known resistance mechanisms and compared it with RT-qPCR. Referring to efflux systems, we found a more robust relative quantification of antibiotic resistance mechanisms by SRM than RT-qPCR. The SRM-based approach was applied to a set of clinical P. aeruginosa isolates to detect antibiotic resistance proteins. This multiplexed SRM-based approach is a rapid and reliable method for the simultaneous detection and quantification of resistance mechanisms and we demonstrate its relevance for antibiotic resistance prediction.
引用
收藏
页数:10
相关论文
共 45 条
[1]   Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides [J].
Aires, JR ;
Köhler, T ;
Nikaido, H ;
Plésiat, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2624-2628
[2]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[3]  
BISBE J, 1988, REV INFECT DIS, V10, P629
[4]   Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study [J].
Cabot, Gabriel ;
Ocampo-Sosa, Alain A. ;
Tubau, Fe ;
Macia, Maria D. ;
Rodriguez, Cristina ;
Moya, Bartolome ;
Zamorano, Laura ;
Suarez, Cristina ;
Pena, Carmen ;
Martinez-Martinez, Luis ;
Oliver, Antonio .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) :1906-1911
[5]   Options and considerations when selecting a quantitative proteomics strategy [J].
Domon, Bruno ;
Aebersold, Ruedi .
NATURE BIOTECHNOLOGY, 2010, 28 (07) :710-721
[6]   Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR [J].
Dumas, JL ;
van Delden, C ;
Perron, K ;
Köhler, T .
FEMS MICROBIOLOGY LETTERS, 2006, 254 (02) :217-225
[7]   The pros and cons of peptide-centric proteomics [J].
Duncan, Mark W. ;
Aebersold, Ruedi ;
Caprioli, Richard M. .
NATURE BIOTECHNOLOGY, 2010, 28 (07) :659-664
[8]   Current therapies for Pseudomonas aeruginosa [J].
Giamarellou, Helen ;
Kanellakopoulou, Kyriaki .
CRITICAL CARE CLINICS, 2008, 24 (02) :261-+
[9]   Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections [J].
Hocquet, Didier ;
Berthelot, Philippe ;
Roussel-Delvallez, Micheline ;
Favre, Roger ;
Jeannot, Katy ;
Bajolet, Odile ;
Marty, Nicole ;
Grattard, Florence ;
Mariani-Kurkdjian, Patricia ;
Bingen, Edouard ;
Husson, Marie-Odile ;
Couetdic, Gerard ;
Plesiat, Patrick .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (10) :3531-3536
[10]  
Hocquet D, 2007, ANTIMICROB AGENTS CH, V51, P1582, DOI 10.1128/AAC.01334-06